Profile
| Metric | Value |
|---|---|
| Full Name | Indivior PLC |
| Ticker | NASDAQ: INDV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | indivior.com |
| Employees | 1,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $36.30 | |
| Price, 1D Change | +0.12% | |
| Market Cap | $5B | |
| TTM Dividend Yield | - | |
| PE Ratio | 36.13 | |
| Beta | 0.67 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +8.69% | |
| EPS | $0.02 | |
| EPS, 1Y Change | +101.59% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.48 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.02 | |
| EPS Estimate | $2.33 | |
| EPS Est. Change | +15,404.67% | |
| Revenue | $1.19B | |
| Revenue Estimate | $1.19B | |
| Revenue Est. Change | +0.14% | |
| Current Price | $36.30 | |
| Price Target | - | $36.00 |
| Price Tgt. Change | - | -0.81% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.42 | -$0.94 | -166.31% | |
| $1.61 | $0.02 | -99.07% | |
| $2.33 | N/A | +15,404.67% | |
| $2.89 | N/A | +19,176.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.06B | $1.09B | +3.11% | |
| $1.15B | $1.19B | +3.15% | |
| $1.19B | N/A | +0.14% | |
| $1.13B | N/A | -4.60% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +203.22% | |
| Price, 3Y | +65.28% | |
| Market Cap, 1Y | +203.69% | |
| Market Cap, 3Y | +649.98% | |
| Revenue, 1Y | +8.69% | |
| Revenue, 3Y | +50.19% | |
| EPS, 1Y | +101.59% | |
| EPS, 3Y | -98.87% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $36.30 | |
| SMA 200 | $20.83 | |
| SMA 200 vs Price | -42.62% | |
| SMA 50 | $32.84 | |
| SMA 50 vs Price | -9.53% | |
| Beta | 0.67 | |
| ATR | $0.94 | |
| 14-Day RSI | 63.27 | |
| 10-Day Volatility | 22.91% | |
| 1-Year Volatility | 51.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.48 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.19B | |
| EPS | $0.02 | |
| Gross Profit | $930.00M | |
| Gross Margin | 78.28% | |
| Operating Profit | -$23.00M | |
| Operating Margin | -1.94% | |
| Net Income | $2.00M | |
| Net Margin | -4.04% | |
| EBITDA | $34.00M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | -0.96 | |
| Current Ratio | 0.88 | |
| Quick Ratio | 0.69 | |
| Interest Coverage | - | |
| F-Score | 7 | |
| Altman Z-Score | 3.52 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 36.13 | |
| PS Ratio | 3.85 | |
| PB Ratio | -21.92 | |
| EV/EBITDA | 15.26 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$205.00M | |
| Cash & Equivalents | $319.00M | |
| Total Assets | $1.33B | |
| Current Assets | $829.00M | |
| Total Liabilities | $1.68B | |
| Current Liabilities | $946.00M | |
| Total Debt | $375.00M | |
| Short Term Debt | $28.00M | |
| Accounts Payable | $63.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.21B | |
| Operating Expenses | $953.00M | |
| Cost Of Goods Sold | $258.00M | |
| SG&A | $807.00M | |
| D&A | $34.00M | |
| Interest Expense | $0.00 | |
| Income Tax | $5.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $21.00M | |
| CFI | $69.00M | |
| CFF | -$87.00M | |
| Capex | $31.00M | |
| Free Cash Flow | -$10.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | ||
| Craig-Hallum | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Piper Sandler | → | |
| Craig-Hallum | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with INDV
Data Sources & References
- INDV Official Website www.indivior.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1625297/000162828025047530/0001628280-25-047530-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1625297/000162529725000016/0001625297-25-000016-index.htm
- INDV Profile on Yahoo Finance finance.yahoo.com/quote/INDV
- INDV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/indv
FAQ
What is the ticker symbol for Indivior PLC?
The ticker symbol for Indivior PLC is NASDAQ:INDV
Does Indivior PLC pay dividends?
No, Indivior PLC does not pay dividends
What sector is Indivior PLC in?
Indivior PLC is in the Healthcare sector
What industry is Indivior PLC in?
Indivior PLC is in the Specialty & Generic Drug Manufacturers industry
What country is Indivior PLC based in?
Indivior PLC is headquartered in United States
When did Indivior PLC go public?
Indivior PLC initial public offering (IPO) was on December 29, 2014
Is Indivior PLC in the S&P 500?
No, Indivior PLC is not included in the S&P 500 index
Is Indivior PLC in the NASDAQ 100?
No, Indivior PLC is not included in the NASDAQ 100 index
Is Indivior PLC in the Dow Jones?
No, Indivior PLC is not included in the Dow Jones index
When was Indivior PLC last earnings report?
Indivior PLC's most recent earnings report was on October 30, 2025
When does Indivior PLC report earnings?
The next expected earnings date for Indivior PLC is February 19, 2026